NewsRoom Articles - Page 70 of 208

FridayApr 14, 2023 9:00 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) CEO Discusses Positive Results from In Vivo Proof-of-Concept Study of Its Anti-COVID-19 NanoAb Therapy and Additional Pipeline Plans at BIO-Europe Spring

BiondVax Pharmaceuticals is a biotechnology company developing, manufacturing, and commercializing innovative NanoAb immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases Company CEO Amir Reichman recently presented at the BIO-Europe Spring conference, where he talked about BiondVax’s successful preclinical in vivo results of its innovative inhaled COVID-19 treatment and additional pipeline plans The in vivo results have shown that the company’s inhaled COVID-19 therapy, formulated using alpaca-derived nanosized antibodies (“NanoAbs”), resulted in milder and shorter illness, virtually eliminated the virus from the lungs, and prophylactically protected against illness Since he was appointed CEO in early 2021, Reichman…

ThursdayApr 13, 2023 1:45 pm

US Federal Agency Plans to Overhaul Organ Transplant Network

Last month, the U.S. government revealed its plan to overhaul the country’s organ transplant system. The system isn't meeting the needs of many patients, with about 104,000 individuals awaiting organ transplants on the list. It is said that 17 individuals die daily waiting for a transplant, with minority and/or poor patients being overlooked in favor of White and affluent individuals. For almost four decades now, the United Network for Organ Sharing (UNOS) has managed this system. The federal Health Resources and Services Administration administrator, Carole Johnson, has proposed that some of the responsibility shouldered by UNOS be entrusted to other…

ThursdayApr 13, 2023 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Global Trial Targets Unmet Medical Need in Arresting GBM Brain Cancer

Glioblastoma (“GBM”), an aggressive and generally fatal brain cancer, has attracted attention as a significant unmet medical need because of its incurability, claiming the lives of more than 200,000 patients worldwide each year CNS Pharmaceuticals is in the middle of a potentially pivotal global Phase 2 clinical trial for its drug candidate, a novel anthracycline called Berubicin that is apparently unique in its ability to cross the blood-brain barrier to target central nervous system tumors CNS’s clinical trial sites have begun enrolling patients in the United States, France, Spain and Switzerland, with sites prepared to receive patients in Italy as…

WednesdayApr 12, 2023 3:29 pm

Study Explores Effects of MRI Scans During Cancer Treatment

Dutch scientists have found that the majority of brain cancer patients who have repeated MRI scans of their brains in follow-up visits tolerate the sessions quite well. However, if given a choice, most cancer patients would avoid gadolinium-based contrast agents (GBCAs) in cases with diagnostically equivalent results. The research team published its results in the “Journal of Neuro-Oncology” in late March. According to the team, the study findings could allow clinicians to improve the care of patients diagnosed with primary brain tumors, particularly glioma. Gliomas are a deadly type of primary brain tumor that starts growing in the brain or…

TuesdayApr 11, 2023 1:59 pm

Electronic Health Data Could Boost Chronic Disease Surveillance

Accurate and timely information plays a crucial role in maintaining public health. As the recent coronavirus pandemic showed, securing the right information as early as possible can allow for the creation of preventative and mitigation strategies. Even though the worst of the pandemic is now behind us, some lessons we learned, such as the value of transmitting electronic health records (EHR) to public health agencies, will still be significant moving forward. NYU Grossman School of Medicine’s Lorna Thorpe, PhD, and Brian Dixon, PhD, MPA, from Indiana University Richard M. Fairbanks School of Public Health and the Regenstrief Institute, will talk…

TuesdayApr 11, 2023 9:45 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Enrolls First Patient in Switzerland in Its Potentially Pivotal Global GBM Trial, Reports No Exposure to SVB Issues

CNS Pharmaceuticals recently announced it had enrolled the first patient in Switzerland as part of its ongoing potentially pivotal global GBM trial The adaptive, multicenter, open-label, randomized controlled trial is evaluating Berubicin for the treatment of recurrent GBM, the most common primary brain cancer, compared to Lomustine, the current standard of care The enrollment moves the company closer to its goal of undertaking an interim analysis expected in the third quarter of 2023 So far, CNS Pharmaceuticals has opened over 40 of 59 planned clinical trial sites selected across Switzerland, Spain, France, Italy, and the U.S. As an aside, the…

MondayApr 10, 2023 12:49 pm

Everything You Need to Know About Postpartum Hair Loss

The American Pregnancy Association estimates that an estimated 40%–50% of women experience some degree of postpartum hair loss. This condition is characterized by hair shedding after childbirth, typically three months after giving birth. A person with postpartum hair loss loses an average of 300 hairs per day compared to typical hair loss, which is around 50–100 hairs daily. Such significant hair loss often becomes apparent during brushing or washing hair; it can even cause thinning and bald patches in some women. The hair loss usually takes six months on average to resolve, but it can sometimes persist for up to…

ThursdayApr 06, 2023 3:20 pm

Study Describes Link Between Viral infections, Autoimmune Diseases

The recent coronavirus pandemic underscored how dangerous viral infections can be when they get out of hand. The communicable respiratory disease took nearly 7 million lives, bringing the globe to a standstill as countries shut their borders to prevent infections. In a recent study, researchers tried to determine whether similar viral infections and autoimmune diseases were connected. Autoimmune conditions occur when an individual’s immune system mistakes healthy tissue for foreign invaders and begins attacking the body. Although we still don’t know the exact cause of autoimmune diseases, scientists have spent decades studying the underlying mechanisms involved in the development of…

WednesdayApr 05, 2023 1:40 pm

Broad Cancer Analysis Finds Possibility for Tumor Reduction in Nearly All Cancers

Washington University School of Medicine researchers recently revealed that they have potentially discovered a new target for tumor reduction in almost all types of cancer. The researchers found that short DNA segments called transposable elements (TEs), which can travel from one location to another within the genome, present a potential new approach in cancer immunotherapy. The team leveraged data from the Cancer Genome Atlas (TCGA), a massive database with 675 cancer cell lines and more than 20,000 cancer samples of 33 different types of cancer, to generate its findings. The main focus of the research was transposable elements (TEs), which…

TuesdayApr 04, 2023 2:15 pm

Eczema or Asthma Predisposes Individuals to Osteoarthritis

A study by Stanford Medicine researchers has revealed that individuals with eczema or asthma have a higher chance of developing osteoarthritis. The findings suggest the presence of an allergic pathway that could be treated with existing drugs. Scientists have traditionally thought that wear and tear in the cartilage that protects joints and bones are the primary reason behind osteoarthritis. However, the Stanford Medicine study found that inflammation may also play a key role in developing the condition. Researchers from Stanford Medicine teamed up with scientists from the Boston University School of Medicine, the VA Palo Alto Health Care System and…